Your browser doesn't support javascript.
loading
Characterization of nucleolar SUMO isopeptidases unveils a general p53-independent checkpoint of impaired ribosome biogenesis.
Dönig, Judith; Mende, Hannah; Davila Gallesio, Jimena; Wagner, Kristina; Hotz, Paul; Schunck, Kathrin; Piller, Tanja; Hölper, Soraya; Uhan, Sara; Kaulich, Manuel; Wirth, Matthias; Keller, Ulrich; Tascher, Georg; Bohnsack, Katherine E; Müller, Stefan.
Afiliação
  • Dönig J; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Mende H; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Davila Gallesio J; Department of Molecular Biology, University Medical Centre Göttingen, Humboldtallee 23, 37073, Göttingen, Germany.
  • Wagner K; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Hotz P; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Schunck K; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Piller T; PharmBioTec gGmbH, Schiffweiler, Germany.
  • Hölper S; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Uhan S; Sanofi AG, Frankfurt, Germany.
  • Kaulich M; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
  • Wirth M; Sanofi AG, Frankfurt, Germany.
  • Keller U; Department of Hematology, Oncology and Cancer Immunology (Campus Benjamin Franklin), Charité Universitätsmedizin Berlin, corporate member of Freie Universität Berlin and Humboldt-Universität zu Berlin, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Tascher G; German Cancer Consortium (DKTK), Im Neuenheimer Feld 280, 69120, Heidelberg, Germany.
  • Bohnsack KE; Max Delbrück Center, Robert-Rössle-Str. 10, 13125, Berlin, Germany.
  • Müller S; Institute of Biochemistry II, Goethe University Frankfurt, Medical Faculty, Theodor-Stern-Kai 7, 60590, Frankfurt, Germany.
Nat Commun ; 14(1): 8121, 2023 Dec 08.
Article em En | MEDLINE | ID: mdl-38065954
ABSTRACT
Ribosome biogenesis is a multi-step process, in which a network of trans-acting factors ensures the coordinated assembly of pre-ribosomal particles in order to generate functional ribosomes. Ribosome biogenesis is tightly coordinated with cell proliferation and its perturbation activates a p53-dependent cell-cycle checkpoint. How p53-independent signalling networks connect impaired ribosome biogenesis to the cell-cycle machinery has remained largely enigmatic. We demonstrate that inactivation of the nucleolar SUMO isopeptidases SENP3 and SENP5 disturbs distinct steps of 40S and 60S ribosomal subunit assembly pathways, thereby triggering the canonical p53-dependent impaired ribosome biogenesis checkpoint. However, inactivation of SENP3 or SENP5 also induces a p53-independent checkpoint that converges on the specific downregulation of the key cell-cycle regulator CDK6. We further reveal that impaired ribosome biogenesis generally triggers the downregulation of CDK6, independent of the cellular p53 status. Altogether, these data define the role of SUMO signalling in ribosome biogenesis and unveil a p53-independent checkpoint of impaired ribosome biogenesis.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribossomos / Cisteína Endopeptidases / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Ribossomos / Cisteína Endopeptidases / Proteína Supressora de Tumor p53 Idioma: En Ano de publicação: 2023 Tipo de documento: Article